Bay Street News, March, 2025

Netanya, Israel, March 31, 2025 (GLOBE NEWSWIRE) — Silynxcom Ltd. (NYSE American: SYNX) (“Silynxcom” or the “Company”), a manufacturer and […]

Proprietary master cell bank of fibroblast-based spheroids product candidate, CYWC628, completed in accordance with Good Manufacturing Practices after successfully passing […]

NEW HOPE, Pa., March 31, 2025 (GLOBE NEWSWIRE) — Orchestra BioMed Holdings, Inc. (Nasdaq: OBIO, “Orchestra BioMed” or the “Company”), […]

SHANGHAI, March 31, 2025 (GLOBE NEWSWIRE) — ECARX Holdings Inc. (Nasdaq: ECX) (“ECARX” or the “Company”), a global mobility tech […]

BOSTON, March 31, 2025 (GLOBE NEWSWIRE) — – Cue Biopharma, Inc. (Nasdaq: CUE), a clinical-stage biopharmaceutical company developing a novel class of […]

Year over year product revenue increased 26% Operating expenses declined 21% and year over year operating loss decreased 35% Management […]

Year-end highlights include three record product orders and $6.8M in expense reductioneffectively positioning the Company for long-term growth WICHITA, Kan., […]

MIAMI, March 31, 2025 (GLOBE NEWSWIRE) — Wrap Technologies, Inc, (NASDAQ: WRAP) (“Wrap” or, the “Company”), a global leader in […]

SAN DIEGO, March 31, 2025 (GLOBE NEWSWIRE) — American Assets Trust, Inc. (NYSE:AAT) (the “Company”) will announce its first quarter […]

Issues guidance following a transformative year with the Company adding two new business lines, significantly strengthening the Balance Sheet and […]